» Articles » PMID: 22189166

Cdk5: a Multifaceted Kinase in Neurodegenerative Diseases

Overview
Specialty Cell Biology
Date 2011 Dec 23
PMID 22189166
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Since the identification of cyclin-dependent kinase-5 (Cdk5) as a tau kinase and member of the Cdk family almost 20 years ago, deregulation of Cdk5 activity has been linked to an array of neurodegenerative diseases. As knowledge on the etiopathological mechanisms of these diseases evolved through the years, Cdk5 has also been implicated in additional cellular events that are affected under these pathological conditions. From the role of Cdk5 in the regulation of synaptic functions to its involvement in autophagy deregulation, significant insights have been obtained regarding the role of Cdk5 as a key regulator of neurodegeneration. Here, we summarize recent findings on the involvement of Cdk5 in the pathophysiological mechanisms underlying various neurodegenerative diseases.

Citing Articles

Cyclin-dependent kinases (CDKs) are key genes regulating early development of Neptunea arthritica cumingii: evidence from comparative transcriptome and proteome analyses.

Lv F, Ge X, Chang Y, Hao Z BMC Genomics. 2024; 25(1):1221.

PMID: 39701993 PMC: 11660575. DOI: 10.1186/s12864-024-10970-3.


Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer's patients postmortem is associated with abnormal iron homeostasis: implications for patient survival.

Sabbir M Front Cell Dev Biol. 2024; 12:1469751.

PMID: 39669708 PMC: 11634808. DOI: 10.3389/fcell.2024.1469751.


Exploring the role of Cdk5 on striatal synaptic plasticity in a 3-NP-induced model of early stages of Huntington's disease.

Hernandez-Echeagaray E, Miranda-Barrientos J, Nieto-Mendoza E, Torres-Cruz F Front Mol Neurosci. 2024; 17:1362365.

PMID: 39569019 PMC: 11576431. DOI: 10.3389/fnmol.2024.1362365.


S-Nitrosylation of p39 promotes its degradation and contributes to synaptic dysfunction induced by β-amyloid peptide.

Cheng A, Wang J, Li J, Wang J, Xu M, Chen H Commun Biol. 2024; 7(1):1113.

PMID: 39256547 PMC: 11387606. DOI: 10.1038/s42003-024-06832-z.


Understanding neurodevelopmental proteasomopathies as new rare disease entities: A review of current concepts, molecular biomarkers, and perspectives.

Cuinat S, Bezieau S, Deb W, Mercier S, Vignard V, Isidor B Genes Dis. 2024; 11(6):101130.

PMID: 39220754 PMC: 11364055. DOI: 10.1016/j.gendis.2023.101130.